The development and hosting of this resource hub has been sponsored by GSK. This resource hub contains links to clinical resources, some of which may be promotional in nature.



Asthma Image

Expert perspectives in asthma

Dr Neil Martin highlights some of the challenges that our healthcare system faces in the provision of good asthma care and management in the UK.


The IMPACT trial in COPD

The IMPACT trial in COPD

An examination of this landmark trial comparing single inhaler triple therapy with both a LAMA/LABA and an ICS/LABA.

Choosing the right inhaler

Choosing the right inhaler

Information and videos on finding the right device for the right patient, the importance of using devices properly and the impact of critical errors.


Useful respiratory patient resources-homepage-img-500px

Useful respiratory patient resources

From patient diaries to peak flow meters, access a selection of free tools to help your patients get the most from their therapy.

Adverse Events should be reported. Reporting forms and information can be found at or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) prescribing information

Trademarks are owned by or licensed to the GSK group of companies.
Date of preparation: February 2019.